Evidence map›Paper›PMID 37082531›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2023

Colistin resistance in

Carlos Bastidas-Caldes, Salomé Guerrero-Freire, Nimer Ortuño-Gutiérrez, Temmy Sunyoto, Cícero Armídio Gomes-Dias, Maria Soledad Ramírez, William Calero-Cáceres, Anthony D Harries, Joaquín Rey, Jacobus H de Waard and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Antimicrobial resistantOne health (Amsterdam, Netherlands) · 2026
    Review
  3. Article
  4. Microorganisms · 2026
    Review
  5. Veterinary and animal science · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The battle against colistin-resistantNew microbes and new infections · 2023
    Article
  13. Article
  14. Mobile Colistin Resistance (Antibiotics (Basel, Switzerland) · 2023
    Review
  15. Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Carlos Bastidas-CaldesOne Health Research Group Biotecnología Facultad de Ingeniería y Ciencias Aplicadas (FICA) Universidad de las Américas (UDLA) Quito Ecuador One Health Research Group, Biotecnología, Facultad de Ingeniería y Ciencias Aplicadas (FICA), Universidad de las Américas (UDLA), Quito, Ecuador.
Salomé Guerrero-FreirePrograma de Doctorado de Ciencias Veterinarias Facultad de Ciencias Veterinarias Universidad de Buenos Aires Buenos Aires Argentina Programa de Doctorado de Ciencias Veterinarias, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, Buenos Aires, Argentina.
Nimer Ortuño-GutiérrezDamien Foundation Brussels Belgium Damien Foundation, Brussels, Belgium.
Temmy SunyotoMédecins Sans Frontières Operational Centre Brussels Luxembourg Operational Research Unit Luxembourg Médecins Sans Frontières Operational Centre Brussels, Luxembourg Operational Research Unit, Luxembourg.
Cícero Armídio Gomes-DiasDepartment of Basic Health Sciences Federal University of Health Sciences of Porto Alegre (UFCSPA) Porto Alegre Brazil Department of Basic Health Sciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, Brazil.
Maria Soledad RamírezDepartment of Biological Science College of Natural Sciences and Mathematics California State University Fullerton FullertonCalifornia United States of America Department of Biological Science, College of Natural Sciences and Mathematics, California State University Fullerton, Fullerton, California, United States of America.
William Calero-CáceresUniversidad Técnica de Ambato-Resistencia a los Antimicrobianos (UTA RAM) One Health Department of Food and Biotechnology Science and Engineering Universidad Técnica de Ambato Ambato Ecuador Universidad Técnica de Ambato-Resistencia a los Antimicrobianos (UTA RAM) One Health, Department of Food and Biotechnology Science and Engineering, Universidad Técnica de Ambato, Ambato, Ecuador.
Anthony D HarriesInternational Union Against Tuberculosis and Lung Disease Paris France International Union Against Tuberculosis and Lung Disease, Paris, France.
Joaquín ReyUnidad de Patología Infecciosa y Epidemiología Facultad de Veterinaria Universidad de Extremadura Cáceres Spain Unidad de Patología Infecciosa y Epidemiología, Facultad de Veterinaria, Universidad de Extremadura, Cáceres, Spain.
Jacobus H de WaardOne Health Research Group Facultad de Ciencias de la Salud Universidad de las Américas (UDLA) Quito Ecuador One Health Research Group, Facultad de Ciencias de la Salud, Universidad de las Américas (UDLA), Quito, Ecuador.
Manuel CalvopiñaOne Health Research Group Facultad de Ciencias de la Salud Universidad de las Américas (UDLA) Quito Ecuador One Health Research Group, Facultad de Ciencias de la Salud, Universidad de las Américas (UDLA), Quito, Ecuador.
Universidad de Las Américas · ECCalifornia State University, Fullerton · USInternational Union Against Tuberculosis and Lung Disease · FRMédecins Sans Frontières · LUUniversidad de Extremadura · ESUniversidade Federal de Ciências da Saúde de Porto Alegre · BRUniversidad Técnica de Ambato · ECUniversity of Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Colistin is an antibiotic of last resort for treating serious Gram-negative bacterial infections. However, the misuse of colistin, especially as an animal growth promoter, has contributed to increasing antimicrobial resistance, mediated mainly through plasmid transfer of the Methods: Fecal samples were collected from humans and their chickens and pigs in two rural coastal and Amazon regions between April and August 2020. Gram-negative bacteria were isolated and identified using conventional techniques. Phenotypic resistance was determined using the broth microdilution technique, and the Results: A total of 438 fecal samples were obtained from 137 humans, 147 pigs and 154 chickens. The prevalence of Conclusions: Despite a low prevalence of phenotypic resistance to colistin, the high prevalence of the

Indexed as

animalsColistindrug resistanceEcuadorEscherichia coligenes, MDRhumansKlebsiella pneumoniaeoperational research

Identifiers

PMID37082531
PMCPMC10105605
OpenAlexW4365815009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.